Jing-Ren Jeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing-Ren Jeng has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Shyh-Ming Shieh
Taipei, Taiwan, Republic of China
5 shared publicationsChii-Yuan Jeng
Taipei, Taiwan, Republic of China
3 shared publicationsWayne Huey-Herng Sheu
3 shared publicationsHorng-Jyh Harn
Departments of Pathology, China Medical University and Hospital, Taiwan
2 shared publicationsHui-Chong Chiu
Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan, ROC
2 shared publicationsMay Meei-Shyuan Lee
2 shared publications
Latest Publications
- Open Access
- 15 February 2012
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 12 (1) , 6
Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study
Background: Angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms have been associated with acute coronary syndrome (ACS); however, several controversial results have also been found in different studied populations. This hospital-based, emergency room, case-control study in Taiwan retrospectively investigated 111 ACS patients, and 195 non-coronary subjects as a control group, to study the effects of ACE I/D polymorphism in the most urgent ACS patients. ACE I/D polymorphisms were determined by polymerase chain reaction-based assays and their associations with ACS risk, severity, and sudden cardiac death were determined. Results: The ACE DD genotype was associated with ACS incidence. The DD genotype was associated with a significant 4-fold higher risk of ACS in multivariate analysis (odds ratio (OR) = 4.295; 95% confidence interval (CI): 1.436-12.851, p = 0.009), and a 3.35-fold higher risk of acute myocardial infarction. DD genotype carriers also had more than 3-fold higher risks of stenosis in all the three coronary arteries, left anterior descending artery infarction, and anterior wall infarction. In addition, the DD genotype was also associated with a higher risk of sudden cardiac death (OR = 6.484, 95% CI: 1.036-40.598, p = 0.046). Conclusions: This study demonstrated that the ACE DD genotype is an independent risk factor for ACS, and in particular, for acute myocardial infarction. In addition, the ACE DD genotype is also associated with greater ACS severity and a higher risk of sudden cardiac death. ACE genotyping is recommended for patients with a history of ACS, and more intensive preventive care is suggested for patients with the DD genotype.
- 15 February 2012
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 12 (1) , 6
Open AccessAngiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study
Background: Angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms have been associated with acute coronary syndrome (ACS); however, several controversial results have also been found in different studied populations. This hospital-based, emergency room, case-control study in Taiwan retrospectively investigated 111 ACS patients, and 195 non-coronary subjects as a control group, to study the effects of ACE I/D polymorphism in the most urgent ACS patients. ACE I/D polymorphisms were determined by polymerase chain reaction-based assays and their associations with ACS risk, severity, and sudden cardiac death were determined. Results: The ACE DD genotype was associated with ACS incidence. The DD genotype was associated with a significant 4-fold higher risk of ACS in multivariate analysis (odds ratio (OR) = 4.295; 95% confidence interval (CI): 1.436-12.851, p = 0.009), and a 3.35-fold higher risk of acute myocardial infarction. DD genotype carriers also had more than 3-fold higher risks of stenosis in all the three coronary arteries, left anterior descending artery infarction, and anterior wall infarction. In addition, the DD genotype was also associated with a higher risk of sudden cardiac death (OR = 6.484, 95% CI: 1.036-40.598, p = 0.046). Conclusions: This study demonstrated that the ACE DD genotype is an independent risk factor for ACS, and in particular, for acute myocardial infarction. In addition, the ACE DD genotype is also associated with greater ACS severity and a higher risk of sudden cardiac death. ACE genotyping is recommended for patients with a history of ACS, and more intensive preventive care is suggested for patients with the DD genotype.
- 29 December 2011
- Published by Elsevier in Reproductive Toxicology
- Vol. 33 (2) , 233-244
The toxic effect of Amiodarone on valve formation in the developing heart of zebrafish embryos
- 29 December 2011
- Published by Elsevier in Reproductive Toxicology
- Vol. 33 (2) , 233-244
The toxic effect of Amiodarone on valve formation in the developing heart of zebrafish embryos
- 1 March 2011
- Published by Wiley in Phytotherapy Research
- Vol. 25 (10) , 1494-1502
Inhibitory Effect of n‐Butylidenephthalide on Neointimal Hyperplasia in Balloon Injured Rat Carotid Artery
This investigation was designed to determine the inhibitory effects and mechanisms of n‐butylidenephthalide (BP) from Angelica sinensis on smooth muscle cell (SMC) proliferation in vitro and in balloon injured rat carotid artery. Treatment of cultured rat aorta SMC‐derived A7r5 cells with 25–100 μg/mL BP significantly inhibited the proliferation and arrested the cell cycle in G0/G1 phase. BP induced the expression and migration of Nur77 from the nucleus to the cytoplasm. Among signal pathways, JNK and p38 MAPK were phosphorylated after BP treatment. In vivo, the neointimal area of common carotid artery 2 weeks after balloon injury reduced significantly in Sprague‐Dawley rats treated with 150–300 mg/kg BP compared with the control. The proliferative activity indicated by immunohistochemical detection of Ki‐67 positive cells in the neointima was significantly decreased in the 60–300 mg/kg BP treatment groups. The apoptotic activity indicated by cleaved caspase‐3 positive cells and Nur77 positive cells in the neointima was significantly increased in rats treated with 60–300 mg/kg BP. This study demonstrated BP inhibited neointimal hyperplasia in balloon injured rat carotid artery due to its dual effects of proliferative inhibition and apoptotic induction on SMCs. Up‐regulation of Nur77 gene may partly explain the antihyperplasia activity of BP on the neointima. Copyright © 2011 John Wiley & Sons, Ltd.
- 1 March 2011
- Published by Wiley in Phytotherapy Research
- Vol. 25 (10) , 1494-1502
Inhibitory Effect of n‐Butylidenephthalide on Neointimal Hyperplasia in Balloon Injured Rat Carotid Artery
This investigation was designed to determine the inhibitory effects and mechanisms of n‐butylidenephthalide (BP) from Angelica sinensis on smooth muscle cell (SMC) proliferation in vitro and in balloon injured rat carotid artery. Treatment of cultured rat aorta SMC‐derived A7r5 cells with 25–100 μg/mL BP significantly inhibited the proliferation and arrested the cell cycle in G0/G1 phase. BP induced the expression and migration of Nur77 from the nucleus to the cytoplasm. Among signal pathways, JNK and p38 MAPK were phosphorylated after BP treatment. In vivo, the neointimal area of common carotid artery 2 weeks after balloon injury reduced significantly in Sprague‐Dawley rats treated with 150–300 mg/kg BP compared with the control. The proliferative activity indicated by immunohistochemical detection of Ki‐67 positive cells in the neointima was significantly decreased in the 60–300 mg/kg BP treatment groups. The apoptotic activity indicated by cleaved caspase‐3 positive cells and Nur77 positive cells in the neointima was significantly increased in rats treated with 60–300 mg/kg BP. This study demonstrated BP inhibited neointimal hyperplasia in balloon injured rat carotid artery due to its dual effects of proliferative inhibition and apoptotic induction on SMCs. Up‐regulation of Nur77 gene may partly explain the antihyperplasia activity of BP on the neointima. Copyright © 2011 John Wiley & Sons, Ltd.
- 1 January 2008
- Published by European Alliance for Innovation n.o.
Approximating Heart Rate Variability
- 1 January 2008
- Published by European Alliance for Innovation n.o.
Approximating Heart Rate Variability
- 10 July 2007
- Published by S. Karger AG in Cardiology
- Vol. 109 (1) , 25-32
Plasma C-Reactive Protein and 5-Lipoxygenase-Activating Protein Gene Promoter Poly-A Polymorphism in Patients with Coronary Artery Disease
Objectives: The purpose of this study was to explore the possible associations of the 5-lipoxygenase-activating protein (FLAP) poly-A genotype, plasma high-sensitivity C-reactive protein (hsCRP) and the extent score of coronary artery disease (CAD). Methods: The 17A/21A genotypes and plasma hsCRP levels were determined in 555 Chinese patients, 424 with and 131 without CAD. The luciferase reporter assay was performed to explore the functional significance of promoter poly-A polymorphism. Results: CAD patients showed significantly higher plasma hsCRP (p = 0.007) than non-CAD subjects, but no differences in the 17A allele carriers and frequency. The extent score of CAD was significantly correlated with plasma hsCRP (p = 0.03). Furthermore, the 17A allele carriers showed significantly higher hsCRP than the 21A homozygotes (p = 0.02). Multiple linear regression analysis documented an impact of the poly-A genotype on plasma hsCRP (p = 0.03). In vitro, the 17A construct was found to have greater promoter activity than the 21A construct (p = 0.02). Conclusions: The present study demonstrated a significant correlation of FLAP gene promoter 17A allele carriers with higher plasma hsCRP levels in patients with CAD. This association might be related to the increased transcriptional activity of the FLAP gene and the resulting pro-inflammatory effect on the 5-lipoxygenase pathway.
- 10 July 2007
- Published by S. Karger AG in Cardiology
- Vol. 109 (1) , 25-32
Plasma C-Reactive Protein and 5-Lipoxygenase-Activating Protein Gene Promoter Poly-A Polymorphism in Patients with Coronary Artery Disease
Objectives: The purpose of this study was to explore the possible associations of the 5-lipoxygenase-activating protein (FLAP) poly-A genotype, plasma high-sensitivity C-reactive protein (hsCRP) and the extent score of coronary artery disease (CAD). Methods: The 17A/21A genotypes and plasma hsCRP levels were determined in 555 Chinese patients, 424 with and 131 without CAD. The luciferase reporter assay was performed to explore the functional significance of promoter poly-A polymorphism. Results: CAD patients showed significantly higher plasma hsCRP (p = 0.007) than non-CAD subjects, but no differences in the 17A allele carriers and frequency. The extent score of CAD was significantly correlated with plasma hsCRP (p = 0.03). Furthermore, the 17A allele carriers showed significantly higher hsCRP than the 21A homozygotes (p = 0.02). Multiple linear regression analysis documented an impact of the poly-A genotype on plasma hsCRP (p = 0.03). In vitro, the 17A construct was found to have greater promoter activity than the 21A construct (p = 0.02). Conclusions: The present study demonstrated a significant correlation of FLAP gene promoter 17A allele carriers with higher plasma hsCRP levels in patients with CAD. This association might be related to the increased transcriptional activity of the FLAP gene and the resulting pro-inflammatory effect on the 5-lipoxygenase pathway.
- 1 November 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21531633,p. 1-4
Heart Rate Measurement in the Presence of Noises
Heart rate profile related to exercise or other physical activities can be a crucial indicator of individual health according to recent researches. This makes heart rate measurement without interfering ongoing activity plays an important role in medical services and pervasive computing applications. However, there are challenges for wearable apparatuses to measure the heart rate in good accuracy and reliability: the lack of sophisticated signal processing capability and the generation of noises caused by physical activity. In this paper, a robust heart rate measuring algorithm is proposed. Several experiments are conducted to give evidence of the robustness and accuracy of the proposed algorithm
- 1 November 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21531633,p. 1-4
Heart Rate Measurement in the Presence of Noises
Heart rate profile related to exercise or other physical activities can be a crucial indicator of individual health according to recent researches. This makes heart rate measurement without interfering ongoing activity plays an important role in medical services and pervasive computing applications. However, there are challenges for wearable apparatuses to measure the heart rate in good accuracy and reliability: the lack of sophisticated signal processing capability and the generation of noises caused by physical activity. In this paper, a robust heart rate measuring algorithm is proposed. Several experiments are conducted to give evidence of the robustness and accuracy of the proposed algorithm
- 31 May 2006
- Published by S. Karger AG in Cardiology
- Vol. 107 (1) , 30-37
Plasma Adiponectin, T94G Gene Polymorphism and PAI-1 in Patients with and without Hypertension
Background: Reduced adiponectin level has been associated with metabolic syndrome, type 2 diabetes, coronary artery disease and gene polymorphisms, but the interrelationships of T94G genotype, plasma adiponectin and plasminogen activator inhibitor-1 (PAI-1) are less understood. Patients and Methods: The T94G genotypes and plasma levels of adiponectin, and PAI-1 were determined in 568 Chinese patients, 212 with and 356 without hypertension, to study the possible associations of T94G genotype, plasma adiponectin, PAI-1 and blood pressure. Results: Hypertensive patients showed significantly lower plasma adiponectin (9.7 ± 11.1 vs. 11.5 ± 10.0 µg/ml, p = 0.04) and higher PAI-1 (p < 0.001) levels but not significantly greater adiponectin TT genotype percentage (38.7 vs. 33.5%) and T allele frequency (0.620 vs. 0.585) than normotensive subjects. Plasma adiponectin was inversely related to PAI-1 activity (r = –0.09, p = 0.03) and antigen (r = –0.202, p < 0.001). Furthermore, the TT genotypic group showed significantly lower plasma adiponectin level (10.4 ± 10.5 vs. 13.4 ± 10.8 µg/ml, p = 0.03) and higher plasma PAI-1 activity (17.0 ± 9.7 vs. 13.5 ± 7.6 IU/ml, p = 0.003) and antigen (32.3 ± 22.7 vs. 25.9 ± 14.7 ng/ml, p = 0.01) than the GG genotypic group. Multiple linear regression analysis in all study subjects, in men and in normotensives documented an impact of adiponectin T94G genotype on plasma levels of adiponectin (p = 0.007, 0.003 and 0.03) and PAI-1 activity (p = 0.02, 0.03 and 0.04) and antigen (p = 0.03, 0.007 and 0.04) after adjustment for potential confounding factors. Conclusions: The present study demonstrated a significant correlation of the TT genotype with lower plasma adiponectin and higher plasma PAI-1 levels in a Chinese population. The contribution of this genotype seemed greater in men and normotensives. It suggested the adiponectin gene T94G polymorphism might affect the regulation of circulating adiponectin and PAI-1.
- 31 May 2006
- Published by S. Karger AG in Cardiology
- Vol. 107 (1) , 30-37
Plasma Adiponectin, T94G Gene Polymorphism and PAI-1 in Patients with and without Hypertension
Background: Reduced adiponectin level has been associated with metabolic syndrome, type 2 diabetes, coronary artery disease and gene polymorphisms, but the interrelationships of T94G genotype, plasma adiponectin and plasminogen activator inhibitor-1 (PAI-1) are less understood. Patients and Methods: The T94G genotypes and plasma levels of adiponectin, and PAI-1 were determined in 568 Chinese patients, 212 with and 356 without hypertension, to study the possible associations of T94G genotype, plasma adiponectin, PAI-1 and blood pressure. Results: Hypertensive patients showed significantly lower plasma adiponectin (9.7 ± 11.1 vs. 11.5 ± 10.0 µg/ml, p = 0.04) and higher PAI-1 (p < 0.001) levels but not significantly greater adiponectin TT genotype percentage (38.7 vs. 33.5%) and T allele frequency (0.620 vs. 0.585) than normotensive subjects. Plasma adiponectin was inversely related to PAI-1 activity (r = –0.09, p = 0.03) and antigen (r = –0.202, p < 0.001). Furthermore, the TT genotypic group showed significantly lower plasma adiponectin level (10.4 ± 10.5 vs. 13.4 ± 10.8 µg/ml, p = 0.03) and higher plasma PAI-1 activity (17.0 ± 9.7 vs. 13.5 ± 7.6 IU/ml, p = 0.003) and antigen (32.3 ± 22.7 vs. 25.9 ± 14.7 ng/ml, p = 0.01) than the GG genotypic group. Multiple linear regression analysis in all study subjects, in men and in normotensives documented an impact of adiponectin T94G genotype on plasma levels of adiponectin (p = 0.007, 0.003 and 0.03) and PAI-1 activity (p = 0.02, 0.03 and 0.04) and antigen (p = 0.03, 0.007 and 0.04) after adjustment for potential confounding factors. Conclusions: The present study demonstrated a significant correlation of the TT genotype with lower plasma adiponectin and higher plasma PAI-1 levels in a Chinese population. The contribution of this genotype seemed greater in men and normotensives. It suggested the adiponectin gene T94G polymorphism might affect the regulation of circulating adiponectin and PAI-1.
- 31 December 2004
- Published by Elsevier in International Journal of Cardiology
- Vol. 97, S21
S15-02 Fibrinolytic dysfunction in hypertension-role of genetic factors
- 31 December 2004
- Published by Elsevier in International Journal of Cardiology
- Vol. 97, S21
S15-02 Fibrinolytic dysfunction in hypertension-role of genetic factors
- 31 December 2004
- Published by Elsevier in International Journal of Cardiology
- Vol. 97, S47
P1-09 Association of HS-CRP with the severity of coronary artery diasease and myocardial infarction
- 31 December 2004
- Published by Elsevier in International Journal of Cardiology
- Vol. 97, S47
P1-09 Association of HS-CRP with the severity of coronary artery diasease and myocardial infarction
- 1 April 2003
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 16 (4) , 290-296
Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension
The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in white but not yet in Chinese patients. Hypertension might exaggerate the 4G/5G genotype effect on plasma PAI-1. The 4G/5G genotypes and plasma PAI-1 levels were determined in 565 Chinese, 211 with and 354 without hypertension to study the genotype effect and the mode of gene-environment interaction. Hypertensive patients showed significantly higher plasma PAI-1 activity (18.2 +/- 10.0 v 14.6 +/- 8.8 IU/mL, P <.001) than normotensive subjects, and also higher body mass index (BMI) and plasma triglyceride (TG), but had neither significant difference in the 4G allele frequency (0.531 v 0.549) nor in the 4G/4G genotype percentage (24.6% v 26.5%). The 4G/4G genotypic group had higher plasma PAI-1 activity (17.6 +/- 10.2 v 14.5 +/- 7.3 IU/mL, P =.027) than the 5G/5G genotypic groups, but the statistic significance was present in women (18.1 +/- 10.0 v 14.8 +/- 6.9 IU/mL, P =.025) and not in men (17.2 +/- 10.5 v 14.3 +/- 7.7 IU/mL, P =.39) after log transformation. Multiple regression analysis of all cases documented the independent effect of BMI (P =.000), plasma TG (P =.000), age (P =.006), gender (P =.046), and the PAI-1 genotype (4G/4G v 5G/5G, P =.012) on plasma PAI-1 activity. However, the significant association of 4G/4G genotypes with higher plasma PAI-1 activity was present in women (P =.004) but not in men. There was a significant difference (P =.04) on the plasma TG-PAI-1 activity correlations between the 4G/4G (r = 0.521) and 5G/5G (r = 0.117) genotypic groups of hypertensive patients. The present study showed that the 4G/4G genotype was associated with elevated plasma PAI-1 activity in Chinese patients with and without hypertension. The contribution of the PAI-1 genotype seemed larger in women. In hypertensives carrying the 4G/4G genotype, higher TG was correlated with higher PAI-1, suggesting a possible contribution of gene-environmental interaction to their high risk for atherothrombotic disease.
- 1 April 2003
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 16 (4) , 290-296
Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension
The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in white but not yet in Chinese patients. Hypertension might exaggerate the 4G/5G genotype effect on plasma PAI-1. The 4G/5G genotypes and plasma PAI-1 levels were determined in 565 Chinese, 211 with and 354 without hypertension to study the genotype effect and the mode of gene-environment interaction. Hypertensive patients showed significantly higher plasma PAI-1 activity (18.2 +/- 10.0 v 14.6 +/- 8.8 IU/mL, P <.001) than normotensive subjects, and also higher body mass index (BMI) and plasma triglyceride (TG), but had neither significant difference in the 4G allele frequency (0.531 v 0.549) nor in the 4G/4G genotype percentage (24.6% v 26.5%). The 4G/4G genotypic group had higher plasma PAI-1 activity (17.6 +/- 10.2 v 14.5 +/- 7.3 IU/mL, P =.027) than the 5G/5G genotypic groups, but the statistic significance was present in women (18.1 +/- 10.0 v 14.8 +/- 6.9 IU/mL, P =.025) and not in men (17.2 +/- 10.5 v 14.3 +/- 7.7 IU/mL, P =.39) after log transformation. Multiple regression analysis of all cases documented the independent effect of BMI (P =.000), plasma TG (P =.000), age (P =.006), gender (P =.046), and the PAI-1 genotype (4G/4G v 5G/5G, P =.012) on plasma PAI-1 activity. However, the significant association of 4G/4G genotypes with higher plasma PAI-1 activity was present in women (P =.004) but not in men. There was a significant difference (P =.04) on the plasma TG-PAI-1 activity correlations between the 4G/4G (r = 0.521) and 5G/5G (r = 0.117) genotypic groups of hypertensive patients. The present study showed that the 4G/4G genotype was associated with elevated plasma PAI-1 activity in Chinese patients with and without hypertension. The contribution of the PAI-1 genotype seemed larger in women. In hypertensives carrying the 4G/4G genotype, higher TG was correlated with higher PAI-1, suggesting a possible contribution of gene-environmental interaction to their high risk for atherothrombotic disease.